Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Int J Antimicrob Agents. 2018 Jan 11;51(3):468–478. doi: 10.1016/j.ijantimicag.2017.12.032

Table 2.

Underlying cardiac and non-cardiac conditions reported in 100 patients diagnosed with Listeria monocytogenes endocarditis.

Variable Listeria monocytogenes
Endocarditis
(n = 100)
Age, Mean Years (Range) 65 (5 to 87)
Ratio of Male-to-Female Patients 1.7
Underlying Cardiac Conditions (Top 10): (No. of Patients)
  Prosthetic Valve 43
  Valvular Disease 24
  Rheumatic Fever or Heart Disease 13
  Heart Failure 10
  Atrial Fibrillation/Flutter 7
  Angina Pectoralis or Myocardial Infarction 7
  Hypertension 6
  Pacemaker/Defibrillator 4
  Coronary Artery Bypass Graft or Vinberg 4
  Atherosclerosis 4
Underlying Non-cardiac Conditions (Top 10): (No. of Patients)
  Diabetes Mellitus 12
  Malignancy 11
  Chronic Kidney Disease or End Stage Renal Disease 7
  Alcoholism 6
  Immunosuppressive Therapy 5
  Anemia 5
  Human Immunodeficiency Virus 5
  Hemodialysis or Peritoneal Dialysis 4
  Renal or Liver Transplant 3
  Pregnancy or Septic Abortion 3
Medical or Medical + Surgical Therapy: Proportion of Patients With Cure (% Survival)
  Medical 42/59 (71%)
  Medical + Surgical 23/30 (77%)
  Overall Survival 69/98 (70%)